Skip to main content
Resources & Evidence Contact us

Clinical support

None

None

None

Supporting healthcare professionals

More than just reliably delivering nutritional products, we’re also your clinical partner. This is why we’re always working to advance the understanding and add to the growing body of clinical evidence around human milk. We’re here with medical, clinical, economic, and research support.

Getting the most out of an EHMD

Clinical evidence

Understand the evidence behind the reductions in bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP), late-onset sepsis, and necrotizing enterocolitis (NEC)

Clinical value

Learn about cost savings, complication reductions, and health outcomes associated with the use of our human milk–based nutritional products

Clinical resources

Get guidance and see how other hospitals are leveraging an EHMD

Talk to our clinical experts

Prolacta Clinical Advisory Board (PCAB)

We are a group of multidisciplinary, independent clinicians who are passionate about human milk science and nutrition. After witnessing first-hand the improved patient outcomes of an Exclusive Human Milk Diet (EHMD) with our patients, we work to enhance clinical practice, education, and outcomes for critically ill infants by sharing clinical expertise and emerging research.

Email: pcab@prolacta.com

Safely helping premature infants grow

A growing body of clinical evidence supports the use of an EHMD, including Prolacta’s 100% human milk–based fortifiers, as a new standard of care for premature infants born weighing ≤1250 g.1

Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol. 2016;36(3):216-220. doi:10.1038/jp.2015.168

,2

Hair AB. Evaluation of the use of human milk cream to decrease length of stay in extremely premature infants. ClinicalTrials.gov identifier: NCT02475434. June 18, 2015. Updated October 14, 2021. Accessed May 19, 2020. https://clinicaltrials.gov/ct2/show/NCT02475434

,3

Huston R, Lee M, Rider E, et al. Early fortification of enteral feedings for infants <1250 grams birth weight receiving a human milk diet including human milk based fortifier. J Neonatal Perinatal Med. 2020;13(2):215-221. doi:10.3233/NPM-190300

,4

Visuthranukul C, Abrams SA, Hawthorne KM, Hagan JL, Hair AB. Premature small for gestational age infants fed an exclusive human milk-based diet achieve catch-up growth without metabolic consequences at 2 years of age. Arch Dis Child Fetal Neonatal Ed. 2019;104(3);F242–F247. doi:10.1136/archdischild-2017-314547

Enhanced protocols with earlier fortification using Prolacta’s fortifiers have been associated with achieving adequate growth,3

Huston R, Lee M, Rider E, et al. Early fortification of enteral feedings for infants <1250 grams birth weight receiving a human milk diet including human milk based fortifier. J Neonatal Perinatal Med. 2020;13(2):215-221. doi:10.3233/NPM-190300

,5

Hair AB, Hawthorne KM, Chetta KE, Abrams SA. Human milk feeding supports adequate growth in infants ≤ 1250 grams birth weight. BMC Res Notes. 2013;6:459. doi:10.1186/1756-0500-6-459

,6

Huston RK, Markell AM, McCulley EA, Gardiner SK, Sweeney SL. Improving growth for infants ≤1250 grams receiving an exclusive human milk diet. Nutr Clin Pract. 2018;33(5):671-678. doi:10.1002/ncp.10054

improved lung health,2

Hair AB. Evaluation of the Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants. ClinicalTrials.gov identifier: NCT0247543. June 10, 2015. Updated December 24, 2019. Accessed May 19, 2020. https://clinicaltrials.gov/ct2/show/NCT02475434

,3

Huston R, Lee M, Rider E, et al. Early fortification of enteral feedings for infants <1250 grams birth weight receiving a human milk diet including human milk based fortifier. J Neonatal Perinatal Med. 2020;13(2):215-221. doi:10.3233/NPM-190300

a lower risk of complications,7

Abrams SA, Schanler RJ, Lee ML, Rechtman DJ. Greater mortality and morbidity in extremely preterm infants fed a diet containing cow milk protein products. Breastfeed Med. 2014;9(6):281-285. doi:10.1089/bfm.2014.0024

,8

Cristofalo EA, Schanler RJ, Blanco CL, et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr. 2013;163(6):1592-1595.e1. doi:10.1016/j.jpeds.2013.07.011

,9

Sullivan S, Schanler RJ, Kim JH, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. 2010;156(4):562-567. doi:10.1016/j.jpeds.2009.10.040

reduced healthcare costs,1

Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol. 2016;36(3):216-220. doi:10.1038/jp.2015.168

,10

Ganapathy V, Hay JW, Kim JH. Costs of necrotizing enterocolitis and cost-effectiveness of exclusively human milk-based products in feeding extremely premature infants. Breastfeed Med. 2012;7(1):29-37. doi:10.1089/bfm.2011.0002

and shorter NICU stays1

Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol. 2016;36(3):216-220. doi:10.1038/jp.2015.168

for infants receiving an EHMD.

This latest study by lead author Robert Huston, MD, published in the Journal of Neonatal-Perinatal Medicine,3

Huston R, Lee M, Rider E, et al. Early fortification of enteral feedings for infants <1250 grams birth weight receiving a human milk diet including human milk based fortifier. J Neonatal Perinatal Med. 2020;13(2):215-221. doi:10.3233/NPM-190300

found that fortification with Prolacta’s 100% human milk–based fortifiers in the first days of life improves growth and reduces the risk of BPD by 15% for infants receiving an EHMD, without the increased risk of complications seen with cow milk–based fortifiers.

The Huston et al (2020) early fortification study provides further data to support the practice of fortifying the human milk feedings of infants born at <1250 g birth weight with a 100% human milk–based fortifier at a lower feeding volume (<60 mL/kg/day) than has been a standard feeding practice in the past.

Tell us how we can help

Clinician-to-clinician guidance

Coding, billing, and reimbursement questions

Finding my sales representative

Support with an order

Citations

1 Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol. 2016;36(3):216-220. doi:10.1038/jp.2015.168

2 Hair AB. Evaluation of the use of human milk cream to decrease length of stay in extremely premature infants. ClinicalTrials.gov identifier: NCT02475434. June 18, 2015. Updated October 14, 2021. Accessed May 19, 2020. https://clinicaltrials.gov/ct2/show/NCT02475434

3 Huston R, Lee M, Rider E, et al. Early fortification of enteral feedings for infants <1250 grams birth weight receiving a human milk diet including human milk based fortifier. J Neonatal Perinatal Med. 2020;13(2):215-221. doi:10.3233/NPM-190300

4 Visuthranukul C, Abrams SA, Hawthorne KM, Hagan JL, Hair AB. Premature small for gestational age infants fed an exclusive human milk-based diet achieve catch-up growth without metabolic consequences at 2 years of age. Arch Dis Child Fetal Neonatal Ed. 2019;104(3);F242–F247. doi:10.1136/archdischild-2017-314547

5 Hair AB, Hawthorne KM, Chetta KE, Abrams SA. Human milk feeding supports adequate growth in infants ≤ 1250 grams birth weight. BMC Res Notes. 2013;6:459. doi:10.1186/1756-0500-6-459

6 Huston RK, Markell AM, McCulley EA, Gardiner SK, Sweeney SL. Improving growth for infants ≤1250 grams receiving an exclusive human milk diet. Nutr Clin Pract. 2018;33(5):671-678. doi:10.1002/ncp.10054

7 Abrams SA, Schanler RJ, Lee ML, Rechtman DJ. Greater mortality and morbidity in extremely preterm infants fed a diet containing cow milk protein products. Breastfeed Med. 2014;9(6):281-285. doi:10.1089/bfm.2014.0024

8 Cristofalo EA, Schanler RJ, Blanco CL, et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr. 2013;163(6):1592-1595.e1. doi:10.1016/j.jpeds.2013.07.011

9 Sullivan S, Schanler RJ, Kim JH, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. 2010;156(4):562-567. doi:10.1016/j.jpeds.2009.10.040

10 Ganapathy V, Hay JW, Kim JH. Costs of necrotizing enterocolitis and cost-effectiveness of exclusively human milk-based products in feeding extremely premature infants. Breastfeed Med. 2012;7(1):29-37. doi:10.1089/bfm.2011.0002